This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
How you reward KeyAccountManagers is seen as a critical ingredient in the overall success of any KeyAccountManagement KAM strategy. The role of a keyaccountmanager requires effective coordination of a web of complex activities. Reward schemes fall into three categories: .
How you reward KeyAccountManagers is seen as a critical ingredient in the overall success of any KeyAccountManagement KAM strategy. The role of a keyaccountmanager requires effective coordination of a web of complex activities. . Reward schemes fall into three categories: 1.
Over the past decade, macro trends in healthcare have pushed life sciences companies to pursue increasingly sophisticated keyaccountmanagement (KAM) strategies and capabilities to provide unique offerings and value. How should leading pharma companies respond? healthcare ecosystem. Understanding Trends.
Pharmaceutical commercial teams struggle to understand what is defined as healthcare customer “ecosystems”. In this case, what is the issue for Pharma? So, what do pharmaceutical commercial teams need to understand about healthcare customer ecosystems? Because the changing dynamics make it more complex day by day.
Pharmaceutical commercial teams struggle to understand what is defined as healthcare customer “ecosystems”. In this case, what is the issue for Pharma? So, what do pharmaceutical commercial teams need to understand about healthcare customer ecosystems? Because the changing dynamics make it more complex day by day.
Traditionally the pharma industry relied on the volume of prescriptions made. A primary challenge for pharma and bio-tech companies is how to identify the right stakeholders in the approval process. Pharma and bio-tech companies need to adopt more innovative market access tactics to succeed.
Traditionally the pharma industry relied on the volume of prescriptions made. the evolving healthcare industry, pharma and bio-tech companies are now focusing on each component of market access: – Price. A primary challenge for pharma and bio-tech companies is how to identify the right stakeholders in the approval process.
The Nationwide Pharma Marketing Excellence Awards 2022 are designed to recognize individuals who have contributed to developing innovative pharmaceutical products and services that may aid in providing patients with top-notch healthcare. Nationwide Pharma Marketing Excellence Awards-Winners list for 2022.
Here, I’ll examine some common elements that I consider essential in today’s medical sales for the pharma or medical device business. As in many other businesses very often 80% of the sales come from 20% of the customers. Keyaccountmanagement Strictly related to the previous point comes the keyaccountmanagement philosophy.
A global head of sales at a pharma company recently told me that “only 15% of our sales calls end in a positive outcome.”. Why is success in pharma sales so hard? Pharma has always been highly restrictive in terms of the different tools you can use to engage, educate and inform about prescription medicines.
In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Given the demand to deliver a steady stream of content to meet HCPs’ needs, pharma marketers must react, create, edit, and adapt quickly. And in 2023, these investments will hopefully pay off.
But three key factors that will drive future success include: Understanding the logistical challenges to healthcare promotion during the pandemic. It’s also important to understand that future interactions with healthcare professionals may be fundamentally altered. Focus Field-based Personnel Goals.
I’ve worked in the pharmaceutical industry full-time for 24 years across a variety of roles but mostly within Leadership and Market Access, and latterly heading up KeyAccountManagement at Boehringer-Ingelheim. Our pharma partners see this as one of the most valuable assets we have to offer.
John is a sales leader that comes from the healthcare sales space and has been in the industry for many years. It could be in the commercial industry, the financial industry, and different organizations as well as healthcare. It’s probably the biggest percentage of our healthcare market. Now, he works for a company.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content